Juraj Staník

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

Pamela Bowman, Åsta Sulen, Fabrizio Barbetti et al. · The Lancet Diabetes & Endocrinology · 2018 · 169 citations · Full text

De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed

Juraj Staník, Petra Dušátková, Ondřej Cinek et al. · Diabetologia · 2013 · 117 citations

Genetic Disorder, Genetics, Molecular Biology +6

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

G Thanabalasingham, N. Jon Shah, Martine Vaxillaire et al. · Diabetologia · 2011 · 117 citations · Full text

Metabolic Syndrome, Biomarker (Medicine), Diabetes +11

Prevalence of Permanent Neonatal Diabetes in Slovakia and Successful Replacement of Insulin with Sulfonylurea Therapy in KCNJ11 and ABCC8 Mutation Carriers

Juraj Staník, Daniela Gašperíková, Magdalena Paskova et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 109 citations · Full text

Mutations in <i>HNF1A</i> Result in Marked Alterations of Plasma Glycan Profile

Gaya Thanabalasingham, Jennifer E. Huffman, Jayesh J. Kattla et al. · Diabetes · 2012 · 106 citations · Full text

Engineering, Hnf1a Dysfunction, Glycobiology +21